Therefore, we aimed at, for the first time in mainland China, assessing the germline mutation of FANCC in high-risk breast cancer patients in women from eastern China, by screening the complete coding regions and exon-intron boundaries of FANCC. This evidence concerns the gene FANCC and breast cancer.